ANAPHYLAXIS
Clinical trials for ANAPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new ANAPHYLAXIS trials appear
Sign up with your email to follow new studies for ANAPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Milk allergy treatment shows promise in Long-Term Follow-Up study
Disease control CompletedThis study looked at the long-term effects of oral immunotherapy (OIT) for children with severe milk allergy. Researchers wanted to see if OIT helps children drink more milk over time and improves their quality of life. They also studied the cost of the treatment. The study inclu…
Matched conditions: ANAPHYLAXIS
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New study checks if drug allergy tests during surgery are safe and accurate
Knowledge-focused CompletedThis study looked at how safe and useful it is to give small doses of anesthetic drugs to people who have had allergic reactions during surgery. Fifty adults who had a history of such reactions took part. The goal was to see if these drug challenge tests could confirm allergies b…
Matched conditions: ANAPHYLAXIS
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated May 26, 2026 06:52 UTC
-
Study reveals hidden dangers: second wave of allergic reactions in kids
Knowledge-focused CompletedThis study looked back at the medical records of 67 children treated for anaphylaxis (a severe allergic reaction) in a hospital emergency department over 10 years. The goal was to find out how long doctors watched them, how often a second wave of symptoms (biphasic reaction) occu…
Matched conditions: ANAPHYLAXIS
Sponsor: Aydin Adnan Menderes University • Aim: Knowledge-focused
Last updated May 26, 2026 06:51 UTC
-
New Under-the-Tongue epinephrine could replace allergy shots
Knowledge-focused CompletedThis study tested a new drug called L-dipivefrin (IN-001) given under the tongue as a spray or drops, compared to standard epinephrine injections, in 32 healthy adults. The goal was to see how the body absorbs the drug and how it affects blood pressure and heart rate. This is an …
Matched conditions: ANAPHYLAXIS
Phase: PHASE1 • Sponsor: Insignis Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC